Table 4.
Medical therapy at discharge
| All | Group 1 - No AF | Group 2 - New onset AF | p | |
|---|---|---|---|---|
| Aspirin | 96.2 | 96.3 | 93.1 | 0.005 |
| Clopidogrel | 80.3 | 80.2 | 81.3 | 0.634 |
| Ticagrelor | 19.3 | 19.6 | 13.7 | 0.065 |
| Prasugrel | 0.3 | 0.3 | 0 | 1.000 |
| Other AP | 4.9 | 5.0 | 3.6 | 0.289 |
| Vitamin K antagonists | 2.4 | 1.9 | 11.2 | < 0.001 |
| NOACs | 1.2 | 0.8 | 7.9 | < 0.001 |
| Beta-blockers | 81.6 | 82.2 | 71.1 | < 0.001 |
| ACE inhibitors/ARB | 87.7 | 88.0 | 81.3 | < 0.001 |
| Aldosterone antagonists | 12.0 | 11.2 | 26.0 | < 0.001 |
| Diuretics | 20.1 | 18.7 | 46.6 | < 0.001 |
| Amiodarone | 2.4 | 1.1 | 26.4 | < 0.001 |
| Other antiarrhythmic drugs | 0.1 | 0.1 | 0 | 1.000 |
| Digitalis | 0.4 | 0.2 | 4.0 | < 0.001 |
Values are percentage (%). AF: atrial fibrillation; NOAC: non vitamin K anticoagulant.